SQS - ETF AI Analysis
Top Page
Sapient Quality Select ETF (SQS)
SQS (Sapient Quality Select ETF) earns a solid overall rating thanks to its heavy exposure to high-quality tech leaders like Alphabet, Apple, Microsoft, and Nvidia, which benefit from strong financial performance and long-term growth drivers in AI, cloud, and services. The fund’s score is held back somewhat by holdings such as Vistra Energy, Amazon, and JPMorgan, where high leverage, cash flow challenges, or premium valuations introduce more uncertainty. The main risk factor is the ETF’s concentration in large technology names, which can make performance more sensitive to shifts in tech valuations and market sentiment.
SQS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.34B
- Region
- Global
- Expense Ratio
- 0.80%
- Beta
- 1.17
- Issuer
- Sapient
- Inception Date
- Mar 13, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
SQS Summary
Sapient Quality Select ETF (SQS) is an actively managed fund that focuses on “quality growth” companies, mainly in the U.S., rather than tracking a fixed index. It looks for profitable, financially strong businesses with good growth prospects across sectors like technology, healthcare, and consumer companies. Well-known holdings include Nvidia, Apple, Microsoft, and Amazon. Someone might invest in SQS to seek long-term growth while staying diversified across many leading companies. A key risk is that it leans heavily toward tech and growth stocks, so its price can rise and fall more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.80%, which means you’ll pay about $8 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, with professionals selecting and monitoring a focused portfolio of quality growth companies around the world.
What would affect this ETF?
This ETF is heavily invested in global technology and other growth-focused companies like Nvidia, Alphabet, and Apple, so it could benefit from ongoing innovation, rising demand for artificial intelligence, cloud computing, and healthcare breakthroughs, as well as a stable or falling interest-rate environment that tends to support growth stocks. On the other hand, it could be hurt by higher interest rates, stricter tech regulations, economic slowdowns that reduce consumer and business spending, or a broad market shift away from growth and quality themes toward more defensive or value-oriented areas.
SQS Top 10 Holdings
This ETF is powered by a Big Tech and AI engine, with Nvidia, Apple, Microsoft, and Alphabet sitting in the driver’s seat. Microsoft and Apple have been rising steadily, giving the fund a solid backbone, while Nvidia’s recent wobble and Alphabet’s mixed stretch have taken a bit of shine off the tech-heavy tilt. Micron and Meta add more AI and digital advertising fuel, though Micron’s near-term swings can make the ride bumpy. Eli Lilly brings strong healthcare momentum, and overall the portfolio leans global but is clearly anchored in U.S. growth leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NVDA | Nvidia | 9.45% | $127.60M | $4.98T | 0.72% | 76Outperform |
 AAPL | Apple | 7.77% | $104.93M | $4.84T | 29.43% | 79Outperform |
 GOOGL | Alphabet Class A | 6.34% | $85.60M | $3.41T | 4.10% | 85Outperform |
 LLY | Eli Lilly & Co | 6.07% | $81.94M | $1.33T | 56.36% | 72Outperform |
 MSFT | Microsoft | 5.96% | $80.46M | $3.87T | 8.06% | 79Outperform |
 AMZN | Amazon | 5.51% | $74.37M | $2.71T | 6.70% | 71Outperform |
 VST | Vistra Corp | 3.99% | $53.81M | $46.85B | -35.24% | 65Neutral |
 AVGO | Broadcom | 3.75% | $50.67M | $1.59T | -7.52% | 76Outperform |
 MU | Micron | 3.72% | $50.27M | $967.48B | 264.73% | 79Outperform |
 JPM | JPMorgan Chase | 3.31% | $44.74M | $898.41B | 13.86% | 72Outperform |
SQS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SQS, the sentiment is Negative. The current price of 27.25 is below the 20-day moving average (MA) of 27.74, below the 50-day MA of 27.99, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 42.31 is Neutral, neither overbought nor oversold. The STOCH value of 19.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SQS.
SQS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| SQS | $27.25 | $31.00(13.77% Upside) | $1.34B | 0.80% | 74Outperform |
 FWD | $116.85 | $166.97(42.89% Upside) | $3.12B | 0.65% | 64Neutral |
 ALAI | $40.72 | $64.41(58.17% Upside) | $2.47B | 0.58% | 67Neutral |
 ARKG | $49.69 | $66.61(34.05% Upside) | $2.15B | 0.75% | 53Neutral |
 BKGI | $43.12 | $48.10(11.55% Upside) | $1.95B | 0.55% | 67Neutral |
 ARKQ | $107.74 | $181.80(68.74% Upside) | $1.74B | 0.75% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SQS | Sapient Quality Select ETF | 27.25 | 1.93 | 7.64% | |
| FWD | AB Disruptors ETF | 116.85 | 11.62 | 11.04% | |
| ALAI | Alger AI Enablers & Adopters ETF | 40.72 | 4.39 | 12.07% | |
| ARKG | ARK Genomic Revolution ETF | 49.69 | 21.33 | 75.21% | |
| BKGI | BNY Mellon Global Infrastructure Income ETF | 43.12 | 4.30 | 11.07% | |
| ARKQ | ARK Autonomous Technology & Robotics ETF | 107.74 | -5.43 | -4.80% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.